Literature DB >> 8387091

A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression.

D I Godfrey1, J Kennedy, T Suda, A Zlotnik.   

Abstract

We have subdivided mouse CD4-CD8-CD3- triple-negative (TN) thymocytes into four subsets based upon expression of CD44 and CD25, including CD44+CD25-, CD44+CD25+, CD44-CD25+ and CD44-CD25-. Characterization of these cells revealed several features distinct to each subset, in particular the expression of high levels of c-kit (the receptor for stem cell factor) by CD44+CD25-TN and CD44+CD25+TN but not by CD44-CD25+TN and CD44-CD25-TN. The CD44+CD25+TN subset also included the IL-7 and stem cell factor-responsive cells, whereas only minimal responsiveness was observed by the CD44- populations. These subsets also showed differential cytokine production potential (CD44+CD25- > CD44+CD25+ > CD44-CD25+ > CD44-CD25-) after stimulation with calcium ionophore, PMA and IL-1. The repopulation potential of these subsets in 2-deoxyguanosine-treated fetal thymic lobes supports the following maturation sequence: CD44+CD25- -->CD44+CD25+ -->CD44-CD25+ -->CD44-CD25-. Furthermore, the sequence of progression from CD44+CD25+ to CD44-CD25+ cells was confirmed by their TCR beta-chain gene configuration. The former population exhibits germ-line TCR beta-chain configuration, whereas the latter subset shows a rearranged pattern.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387091

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  218 in total

1.  Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow.

Authors:  S Dejbakhsh-Jones; S Strober
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 2.  Thymic involution in aging.

Authors:  R Aspinall; D Andrew
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

3.  Conditional ablation of T-cell development by a novel viral ion channel transgene.

Authors:  Claire A Smith; Christine M Graham; Kathleen Mathers; Anita Skinner; Alan J Hay; Cornelia Schroeder; D Brian Thomas
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 4.  A genetic investigation of E2A function in lymphocyte development.

Authors:  J Hanrahan; L Pan; S Greenbaum; C Bradney; M Hjelmeland; M Dai; Y Zhuang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  Identification of the earliest natural killer cell-committed progenitor in murine bone marrow.

Authors:  John W Fathman; Deepta Bhattacharya; Matthew A Inlay; Jun Seita; Holger Karsunky; Irving L Weissman
Journal:  Blood       Date:  2011-09-19       Impact factor: 22.113

6.  The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development.

Authors:  J D Alvarez; D H Yasui; H Niida; T Joh; D Y Loh; T Kohwi-Shigematsu
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

7.  Detailed analysis of gene expression during development of T cell lineages in the thymus.

Authors:  Nami McCarty; Mari L Shinohara; Linrong Lu; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-09       Impact factor: 11.205

8.  Immature single-positive CD8+ thymocytes represent the transition from Notch-dependent to Notch-independent T-cell development.

Authors:  Juan Xiong; Michael A Armato; Thomas M Yankee
Journal:  Int Immunol       Date:  2010-12-09       Impact factor: 4.823

9.  Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage.

Authors:  Zheng Zhang; Claudiu V Cotta; Robert P Stephan; Cristina G deGuzman; Christopher A Klug
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

10.  Phospholipase Cγ1 is required for pre-TCR signal transduction and pre-T cell development.

Authors:  Guoping Fu; Mei Yu; Yuhong Chen; Yongwei Zheng; Wen Zhu; Debra K Newman; Demin Wang; Renren Wen
Journal:  Eur J Immunol       Date:  2016-11-07       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.